美国卫生部长肯尼迪：愿意与民主党合作制定降低药品价格的立法。

Group 1 - The core viewpoint is that U.S. Health Secretary Kennedy is willing to collaborate with the Democratic Party to create legislation aimed at reducing drug prices [1] Group 2 - The initiative reflects a growing concern over high prescription drug costs in the U.S. healthcare system [1] - The collaboration may lead to significant changes in drug pricing policies, impacting pharmaceutical companies and consumers alike [1]